BeOne Medicines (ONC) Prepaid Assets (2015 - 2026)

BeOne Medicines' (ONC) quarterly Prepaid Assets came in at $190.0 million in Q1 2026, up 12.97% year-on-year from $168.2 million in Q1 2025, and down 10.7% on a QoQ basis from $212.8 million in Q4 2025.

BeOne Medicines (ONC) Prepaid Assets (2015 - 2026) Analysis & Trends

BeOne Medicines (ONC) has 12 years of Prepaid Assets data on file, last reported at $190.0 million in Q1 2026.

  • On a quarterly basis, Prepaid Assets rose 12.97% year-over-year to $190.0 million in Q1 2026; TTM through Mar 2026 was $190.0 million, a 12.97% increase from a year earlier, with the FY2025 full-year figure at $212.8 million, up 10.28% from the prior year.
  • Prepaid Assets for Q1 2026 stood at $190.0 million, down from $212.8 million in the prior quarter.
  • Over the last five years, Prepaid Assets for ONC reached as high as $1.4 billion in Q4 2022 and fell as low as $168.2 million in Q1 2025.
  • Historically, Prepaid Assets has averaged $296.4 million across 5 years, with a median of $232.6 million in 2025.
  • Across the five-year window, Prepaid Assets soared 401.27% in 2022 and sank 80.99% in 2023, its largest moves.
  • Year by year, Prepaid Assets stood at $1.4 billion in 2022, then sank by 80.99% to $257.5 million in 2023, then declined by 25.07% to $192.9 million in 2024, then advanced by 10.28% to $212.8 million in 2025, then decreased by 10.7% to $190.0 million in 2026.
  • Per Business Quant data, the three most recent Prepaid Assets figures were $190.0 million in Q1 2026, $212.8 million in Q4 2025, and $232.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 190.00 Mn
Dec 31, 2025 212.75 Mn
Sep 30, 2025 232.64 Mn
Jun 30, 2025 280.52 Mn
Mar 31, 2025 168.18 Mn
Dec 31, 2024 192.92 Mn
Sep 30, 2024 209.08 Mn
Jun 30, 2024 273.66 Mn
Mar 31, 2024 231.74 Mn
Dec 31, 2023 257.47 Mn
Sep 30, 2023 241.66 Mn
Jun 30, 2023 255.05 Mn
Mar 31, 2023 264.84 Mn
Dec 31, 2022 1.35 Bn
Sep 30, 2022 199.77 Mn
Jun 30, 2022 207.38 Mn
Mar 31, 2022 266.44 Mn
Dec 31, 2021 270.17 Mn
Sep 30, 2021 235.02 Mn
Jun 30, 2021 225.46 Mn